Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

The results challenge the rapid growth of Impella support during high-risk PCI. Investigators say a reckoning is needed.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock ...

A Phoenix man survived two cardiac arrests without a heart transplant, and doctors are calling it a miracle. His odds of surviving a transplant were less than 20%.

The GOP candidate for governor ran Abiomed, which has faced warnings from federal regulators and litigation spurred by the ...

Results of lung impedance-guided therapy in HFpEF also anticipated this weekend ...

A combination of left ventricular support plus delayed percutaneous coronary intervention did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock, ...

William Takes Horse had the biggest scare of his life exactly 10 years ago. Doctors at Texoma Medical Center inserted ...

In 2025, we made significant strides towards advancing DrugSorb-ATR - a two-time U.S. Food and Drug Administration (FDA) Breakthrough Device - through the FDA De Novo submission process to reduce ...